Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109538

Effect of Intact Parathyroid Hormone on Hepatic Glucose Release in the Dog

Keith A. Hruska, Joan Blondin, Raymond Bass, Julio Santiago, Lorraine Thomas, Paul Altsheler, Kevin Martin, and Saulo Klahr

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Hruska, K. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Blondin, J. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Bass, R. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Santiago, J. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Thomas, L. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Altsheler, P. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Martin, K. in: PubMed | Google Scholar

Renal and Metabolism Divisions, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Renal and Metabolism Divisions, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Klahr, S. in: PubMed | Google Scholar

Published October 1, 1979 - More info

Published in Volume 64, Issue 4 on October 1, 1979
J Clin Invest. 1979;64(4):1016–1023. https://doi.org/10.1172/JCI109538.
© 1979 The American Society for Clinical Investigation
Published October 1, 1979 - Version history
View PDF
Abstract

The liver has been shown to remove parathyroid hormone (PTH) from its arterial circulation by a mechanism that is selective for the intact form of the peptide (PTH 1-84). The present studies demonstrate that PTH has biologic effects on the liver in vivo. Bovine PTH 1-84 stimulated hepatic glucose release in dogs with indwelling hepatic vein catheters from basal values of 31±8 to 68±9 mg/min per kg after bolus injections of PTH. The effect on hepatic glucose release was apparent by 5 min and persisted for the 80 min of observation. The NH2-terminal PTH fragment (syn b-PTH 1-34) had no effect. Bovine PTH 1-84 administered in doses designed to produce circulating levels of immunoreactive PTH similar to the endogenous levels observed in uremic dogs also increased the incorporation of 14C from infused [14C]alanine into glucose, and increased estimated hepatic uptake of both chemical and [14C]alanine, while increasing hepatic glucose release. Thus, administration of “physiologic levels” of b-PTH 1-84 stimulated hepatic glucose release in part through increased gluconeogenesis in vivo, whereas syn b-PTH 1-34 had no demonstrable effect. Circulating levels of insulin rose after PTH administration, an increase which presumably represents a secondary response to the rise in glucose release.

These results suggest that the liver is a target organ of PTH, and that PTH might potentially alter carbohydrate metabolism during hypersecretion. They also suggest that hepatic uptake of PTH may be related in part to production of a specific biologic effect rather than just simple peptide degradation.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1016
page 1016
icon of scanned page 1017
page 1017
icon of scanned page 1018
page 1018
icon of scanned page 1019
page 1019
icon of scanned page 1020
page 1020
icon of scanned page 1021
page 1021
icon of scanned page 1022
page 1022
icon of scanned page 1023
page 1023
Version history
  • Version 1 (October 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts